Funding for this research was provided by:
AstraZeneca (Not applicable)
Received: 15 July 2020
Accepted: 21 December 2020
First Online: 13 January 2021
Ethics approval and consent to participate
: This study was deemed exempt by the University of Utah Institution Review Board (IRB# 00076204). Administrative permission to access the raw data in this study was granted by The University of Utah IRB.
: Not applicable.
: JB, SU, MY, XY, RD, DS and DB were all members of the University of Utah at the time of this study and received research funding for this study. CT at the time of this study was an employee of AstraZeneca.